AR118682A1 -
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
- Google Patents
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paula Dobrogowska, Schierano Maria CeciliafiledCriticalPaula Dobrogowska
Priority to ARP200102018ApriorityCriticalpatent/AR118682A1/en
Publication of AR118682A1publicationCriticalpatent/AR118682A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Cosmetics
(AREA)
Abstract
Reivindicación 1: Composición natural para el tratamiento de radiodermitis de grado 1, 2, 3 y 4 en forma de emulsión de aplicación tópica, caracterizada porque comprende: entre 20% y 70% en peso de una fase acuosa que comprende un agua termal; entre 20% y 70% en peso de una fase oleosa que comprende un aceite de origen natural, orgánico, rico en omega-9 y a-tocoferol; entre 0,2% y 1% en peso de uno o más emulsionantes no derivados del petróleo; entre 10% y 30% en peso respecto de la composición total, de un compuesto orgánico con actividad como vitamina A.Claim 1: Natural composition for the treatment of grade 1, 2, 3 and 4 radiodermatitis in the form of an emulsion for topical application, characterized in that it comprises: between 20% and 70% by weight of an aqueous phase comprising a thermal water; between 20% and 70% by weight of an oily phase comprising an oil of natural, organic origin, rich in omega-9 and α-tocopherol; between 0.2% and 1% by weight of one or more non-petroleum-derived emulsifiers; between 10% and 30% by weight with respect to the total composition, of an organic compound with activity as vitamin A.
ARP200102018A2020-07-172020-07-17
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
AR118682A1
(en)
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
Cosmetic composition comprising 0.0001 to 10% by weight of guacatonga extract (casearia sylvestris) and 0.00005 to 10% by weight of aroeira extract (schinus terebinthifolius raddi) both with respect to the total weight of the composition; use of the composition in the prevention and / or treatment of signs of skin aging; method to prevent and / or treat the signs of skin aging.
Pharmaceutical composition comprising micronized progesterone and type II safflower oil; and use for the treatment of a condition related to insufficient progesterone secretion.
Use of an emulsion comprising 0.08% by weight or less of antimicrobial essential oil, acacia gum and water to provide an antimicrobial effect in an aqueous composition; process to improve the antimicrobial effect of an antimicrobial essential oil; and aqueous composition comprising an antimicrobial emulsion.
Topical pharmaceutical gel composition comprising a) 0.25 to 4.5% of an active agent for the treatment of actinic keratosis, b) a keratolytically active agent, c) a gel former, d) an organic solvent, and less than 5% by weight of water; Useful for the treatment of actinic keratosis.
DERMOCOSMETIC COMPOSITION, OF NATURAL AND ORGANIC ORIGIN, WITH REPAIRING EFFECTS FOR ONCOLOGICAL PATIENTS WITH RADIODERMITIS; AND PROCEDURE FOR OBTAINING IT
Pharmaceutical composition in the form of an oral suspension comprising as active ingredient a fraction of flavonoid and as an excipient xanthan gum in the amount of 0.30% w / w to 0.60% w / w; use for the treatment of venous insufficiency.